Article

Urology Times welcomes Dr. Rosevear as board member

Urology Times is pleased to welcome Henry Rosevear, MD, to the publication’s Clinical Practice Board.

Dr. Rosevear

 

Urology Times is pleased to welcome Henry Rosevear, MD, to the publication’s Clinical Practice Board.

A blogger for UrologyTimes.com, Dr. Rosevear practices urology at Pikes Peak Urology in Colorado Springs, CO.

Dr. Rosevear completed his urology residency at the University of Iowa Hospital and Clinics in Iowa City, where he had previously completed a general surgery internship. He graduated from the University of Michigan Medical School, Ann Arbor with both academic and research distinction. Before attending medical school, he served as an officer onboard the fast attack submarine USS Pittsburgh.

He has published more than 20 academic articles and numerous book chapters concentrating on urologic oncology.

To read Dr. Rosevear’s blog, which focuses on the challenges and opportunities facing young urologists, visit www.urologytimes.com/Rosevear-blog.

To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.
 

Related Content
zapp2photo - stock.adobe.com
January 29th 2021

Real-time patient access to charts opens up real potential for misinterpretations

Henry Rosevear, MD
"I have no problem with patients seeing everything in their chart. It is their medical record, after all. But I do think there should be some limitations on this access," writes Henry Rosevear, MD.
Jürgen Fälchle - stock.adobe.com
November 16th 2020

From Dr. Rosevear: What I learned about urology in 2020

Henry Rosevear, MD
"The COVID-19 pandemic exposed shortcomings in all current business models of urology," writes Henry Rosevear, MD.
s_l - stock.adobe.com
November 13th 2020

Urologists discuss their music preferences for the OR

Karen Nash
"I listen to whatever my staff actually wants to listen to, except I say ‘no rap’ " says one urologist.
Site Logo
April 25th 2019

The BCG shortage: No short-term solution!

Adele M. Caruso, DNP, CRNP, FAANP
"Bacillus Calmette-Guerin (BCG) intravesical immunotherapy is the most effective treatment for management of our patients with non-muscle invasive bladder cancer. What do we do without it, and how do we explain the current worldwide BCG shortage to our patients?" writes Adele M. Caruso, DNP, CRNP.
Henry Rosevear, MD
April 2nd 2019

Residency vs. the real world: 5 things I wish I’d known

Henry Rosevear, MD
"Just like I’ve learned that the grass really isn’t any greener on the other side, I am learning that life in the trenches of urology, as a small-town urologist, isn't exactly what I thought it would be when I was a resident," writes Dr. Rosevear.
morganka - stock.adobe.com
March 8th 2019

Hematuria evaluation: Evidence for optimal practice?

Adele M. Caruso, DNP, CRNP, FAANP
In this blog post, Adele M. Caruso, DNP, CRNP, summarizes current evidence and guidance for hematuria evaluation as it pertains to clinicians, including advanced practice providers.
© 2024 MJH Life Sciences

All rights reserved.